Concepedia

Ottheinz Krebs

OK

Statistics

Publications

20

Citations

929

H-Index

16

Active since

1991

Affiliations

Ludwig-Maximilians-Universität München(Current)

German Cancer Research Center

Heidelberg University

University Hospital Heidelberg

ORYX (Germany)

Ottheinz Krebs is an author at Ludwig-Maximilians-Universität München specializing in life sciences, virology, and viral infections.

Publications per year

1991–2021

20

Publications

20

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

Karsten Geletneky, Jacek Hajda, Assia L. Angelova et al. · Molecular Therapy · 2017 · 259 citations · Full text

Medicine, Immunology, Oncology +16

Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

Karsten Geletneky, Johannes Huesing, Jean Rommelaere et al. · BMC Cancer · 2012 · 159 citations · Full text

Medicine, Oncology, Surgery +15

Overexpression of Insulin-like Growth Factor-II in Mouse Embryonic Stem Cells Promotes Myogenic Differentiation

Katja Prelle, Anna M. Wobus, Ottheinz Krebs et al. · Biochemical and Biophysical Research Communications · 2000 · 53 citations

Life Sciences, Cell Biology, Developmental Biology +10

Insulin-like Growth Factor-Binding Protein-5 Inhibits Growth and Induces Differentiation of Mouse Osteosarcoma Cells

Marlon R. Schneider, Rui Zhou, Andreas Hoeflich et al. · Biochemical and Biophysical Research Communications · 2001 · 50 citations

Medicine, Cell Biology, Oncology +11

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

Jacek Hajda, Monika Lehmann, Ottheinz Krebs et al. · BMC Cancer · 2017 · 44 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 20